Text Size
Donate

News - All Articles

FDA Clears Self-monitoring Icare Tonometer

The Icare Home tonometer for patient monitoring of intraocular pressure fluctuations throughout the day features an automated measuring sequence that can take either a single measurement or a series of six measurements with one touch of a button.

Read More »

World Glaucoma Week 2017: Glaucoma Research Foundation Announces $1.3 Million in Research Grants

Glaucoma Research Foundation marked World Glaucoma Week today by announcing $1.3 million in research grants.

Read More »

Dr. Richard Libby Awarded 2017 Shaffer Prize for Innovative Glaucoma Research

For his research project “Understanding Axonal Degeneration Pathways in Glaucoma,” Richard T. Libby, PhD from the University of Rochester Medical School in Rochester, New York was awarded the 2017 Shaffer Prize for Innovative Glaucoma Research.

Read More »

Innovations Harness New Technologies for People with Visual Impairment, Blindness

During Low Vision Awareness Month, Glaucoma Research Foundation is sharing this news from the National Eye Institute about innovations that aim to help people with vision loss to more easily accomplish daily tasks.

Read More »

January is Glaucoma Awareness Month

National Glaucoma Awareness Month is an important time to spread the word about this sight-stealing disease that affects more than 3 million people in the United States and 60 million worldwide.

Read More »

Glaucoma Research Foundation to honor renowned ophthalmologist Eugene de Juan, Jr., MD and opera singer Janette Márquez at 11th Annual Gala

The Glaucoma 360 Annual Gala will take place February 2, 2017 at San Francisco's historic Palace Hotel.

Read More »

Glaucoma Research Foundation to Host 6th Annual Glaucoma 360, a three-day event, at the historic Palace Hotel in San Francisco

Glaucoma Research Foundation will host the 6th Annual Glaucoma 360 in San Francisco from February 2 to 4, 2017. This unique three-day event is dedicated to highlighting innovation in glaucoma.

Read More »

Allergan Receives FDA Approval for XEN Glaucoma Treatment System

Allergan has announced that the U.S. Food and Drug Administration (FDA) has cleared the XEN Glaucoma Treatment System (a new MIGS device) for use in the United States.

Read More »

New Research Holds Promise For Restoring Lost Vision

Stanford researchers make discovery that may lead to help for glaucoma patients who have lost vision. Study points toward potential regenerative therapies for damaged cells.

Read More »

Alcon Achieves US Approval for CyPass Micro-Stent MIGS Device

Alcon has achieved United States FDA approval for the CyPass Micro-Stent, a micro-invasive surgical device to treat glaucoma.

Read More »